Patient-directed strategy to reduce prescribing for patients with dyspepsia in general practice: A randomized trial

Alimentary Pharmacology and Therapeutics

Volumn 19, Issue 8, 2004, Pages 917-922

  Krol, N ^a   Wensing, M ^a   Haaijer Ruskamp, F ^b   Muris, J W M ^c   Numans, M E ^d   Schattenberg, G ^a   Van Balen, J ^e   Grol, R ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e DUTCH COLLEGE OF GENERAL PRACTITIONERS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CLINICAL TRIAL; CLUSTER ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DYSPEPSIA; EVALUATION; FEMALE; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; PATIENT SELECTION; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SECONDARY PREVENTION; TREATMENT INDICATION;

DYSPEPSIA; FAMILY PRACTICE; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PATIENT PARTICIPATION; PRESCRIPTIONS, DRUG; PROTON PUMPS; RURAL HEALTH; TREATMENT OUTCOME; URBAN HEALTH;

EID: 2042446408     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.01928.x     Document Type: Article

References (23)

1. Stichting farmaceutische kengetallen. Omzet top 10 geneesmiddelen. 2000, Data en Feiten Selectie, 2001.
2. Van Pinxteren B, Numans ME, Lau J, De Wit NJ, Hungin APS, Bonis PAL. Short-term treatment of gastroesophageal reflux disease. J Gen Int Med 2003; 18: 755-63.
3. Hurenkamp GJ, Grundmeijer HG, Bindels PJ, Tytgat GN, van der Hulst RW. [Chronic use of stomach acid inhibitor medication in family practice in the region of Amsterdam] Chronisch gebruik van maagzuursecretieremmende medicatie in de huisartsenpraktijk in de regio Amsterdam. Ned Tijdschr Geneeskd 1999; 143: 410-3.
4. De Wit NJ, Quartero AO, Numans ME. Helicobacter pylori treatment instead of maintenance therapy for peptic ulcer disease. The effectiveness of a case-finding strategy in general practice. Aliment Pharmacol Ther 1999; 13: 1317-22.
5. Bashford JN, Norwood J, Chapman SR. Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database. BMJ 1998; 317: 452-6.
6. Quartero AO, Smeets HM, de Wit NJ. Trends and determinants of pharmacotherapy for dyspepsia: analysis of 3-year prescription data in The Netherlands. Scand J Gastroenterol 2003; 38: 676-7.
7. Martin RM, Lim AG, Kerry SM, Hilton SR. Trends in prescribing H2-receptor antagonists and proton pump inhibitors in primary care. Aliment Pharmacol Ther 1998; 12: 797-805.
8. Krol N, Spies TH, Van Balen J, Hartman J, Wensing M, Grol R. Managing dyspepsia in general practice: an observational study. Quality in Primary Care 2003; 11: 173-80.
9. Krol N, Muris JWM, Schattenberg G, Wensing M, Grol R. Use of prescribed and non-prescribed drugs for dyspepsia. Scand J Prim Health Care 2004 (in press).
10. Barry CA, Bradley CP, Britten N, Stevenson A, Barber N. Patients' unvoiced agenda in general practice consultations: qualitative study. BMJ 2000; 320: 1246-50.
11. Numans ME, De Wit NJ, Dirven JAM, et al. NHG-standaard Maagklachten (tweede herziening) [Dutch College of General Practitioners Guideline Dyspepsia, second revision]. Huisarts Wet 2003; 46: 690-700.
12. Van der Kuy A(red.) Farmacotherapeutisch Kompas 2000/ 2001. Amstelveen.: College voor Zorgverzekeringen, commissie farmaceutische hulp, 2000.
13. Veldhuyzen-van-Zanten SJ, Tytgat KM, Pollak PT, et al. Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and Helicobacter pylori associated gastritis? J Clin Epidemiol 1993; 46: 273-9.
14. Van der Zee KI, Sanderman R. Het meten van de algemene gezondheidstoestand met de RAND-36. Een handleiding [Measurement of general health with the RAND-36: A manual]. Groningen: Noordelijk Centrum voor Gezondheidsvraagstukken, 1993.
15. Gill PS, Makela M, Vermeulen KM, et al. Changing doctor prescribing behavior: a review. Pharm World & Science 1999; 21: 158-67.
16. Oxman AD, Thomson MA, Davis DA, et al. No magic bullets. A systematic review of 102 trials of intervention to help health care professionals deliver services more effectively or efficiently. Can Med Assoc J 1995; 153: 1423-31.
17. Wensing M, van der Weijden T, Grol R. Implementing guidelines and innovations in general practice: which interventions are effective? Br J Gen Pract 1998; 48: 991-7.
18. Veninga CC, Denig P, Zwaagstra R, Haaijer-Ruskamp FM. Improving drug treatment in general practice. J Clin Epidemiol 2000; 53: 762-72.
19. Veninga CC, Lagerlov P, Wahlstrom R, et al. Evaluating an educational intervention to improve the treatment of asthma in four European countries. Drug Education Project Group. Am J Respir Crit Care Med 1999; 160: 1254-62.
20. Van Eijk MEC, Avorn J, Porsius AJ, De Boer A. Reducing prescribing of highly anticholinergic antidepressants for elderly people: randomised trial of group versus individual academic detailing. BMJ 2001; 322: 654.
21. Pollock K, Grime J. Strategies for reducing the prescribing of proton pump inhibitors (PPIs): patient self-regulation of treatment may be an under-exploited resource. Soc Sci Med 2000; 51: 1827-39.
22. Bashir K, King M, Ashworth M. Controlled evaluation of brief intervention by general practitioners to reduce chronic use of benzodiazepines. Br J Gen Pract 1994; 44: 408-12.
23. Hungin AP, Rubin GP, O'Flanagan H. Long-term prescribing of proton pump Inhibitors in general practice. Br J Gen Pract 1999; 49: 451-3.